Biotech

All Articles

I &amp I biotech Triveni elevates $115M for preclinical antitoxins

.Triveni Bio has actually roped in $115 thousand in set B funds to evolve preclinical antitoxin plan...

IGM rotates coming from cancer to autoimmune, agitating C-suite

.IGM Biosciences finished last year giving up personnel and streamlining its own cancer cells pipeli...

Shattuck axes CD47 program over weak efficiency data, gives up 40% of staff and loses Ono deal

.Shattuck Labs has actually hammered one more nail in to the casket of CD47. After finding a "small"...

BioMarin goes Outdoor camping, striking RNA manage biotech

.BioMarin is adding combustion to the R&ampD fire, attacking a complement along with CAMP4 Therapies...

Cash- strapped Gritstone begins seek strategic alternatives as cancer cells vaccine data underwhelm

.Gritstone bio has actually introduced financiers to explore "prospective value-maximizing technique...

Kailera launches with $400M collection A, 4 Mandarin weight problems medications

.Kailera Rehabs has launched right into the increasingly jampacked obesity space with a collection o...

Metsera join Amneal to lock down GLP-1 supply

.Along with very early phase 1 data right now out in bush, metabolic illness ensemble Metsera is thr...

Rivus articles information to back up muscle-sparing being overweight medicine claims

.Rivus Pharmaceuticals has introduced the data behind its phase 2 being overweight succeed in cardia...

BMS pays $110M to form T-cell therapy deal, aiding Prime purchase opportunity to develop prioritized pipeline

.Bristol Myers Squibb is paying Perfect Medicine $110 million ahead of time to create reagents for e...

Generate gains another $1B-plus Major Pharma collaboration

.Novartis has actually printer inked a deal potentially worth greater than $1 billion along with Fla...